300584 海辰藥業
按盤價 
23.030 -0.190 (-0.818%)
23.030 -0.190 (-0.818%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.815 | 3.748 | 3.414 | 35.075 | 8.280 |
| 總資產報酬率 ROA (%) | 1.986 | 2.687 | 2.500 | 25.889 | 6.221 |
| 投入資產回報率 ROIC (%) | 2.122 | 2.904 | 2.674 | 27.395 | 6.594 | 邊際利潤分析 |
| 銷售毛利率 (%) | 83.104 | 81.346 | 75.304 | 81.150 | 75.710 |
| 營業利潤率 (%) | 8.699 | 7.588 | 5.718 | 57.287 | 8.850 |
| 息稅前利潤/營業總收入 (%) | 10.281 | 8.699 | 6.665 | 58.321 | 9.612 |
| 淨利潤/營業總收入 (%) | 7.799 | 7.013 | 6.102 | 49.252 | 7.720 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 120.721 | 112.609 | 125.643 | 7.510 | 100.742 |
| 價值變動淨收益/利潤總額(%) | -0.393 | 0.106 | 3.229 | 92.697 | 0.127 |
| 營業外收支淨額/利潤總額(%) | -3.810 | -4.254 | -4.605 | -0.258 | -1.891 | 償債能力分析 |
| 流動比率 (X) | 1.054 | 0.943 | 1.193 | 1.002 | 1.623 |
| 速動比率 (X) | 0.782 | 0.739 | 0.991 | 0.819 | 1.228 |
| 資產負債率 (%) | 29.020 | 29.908 | 26.537 | 27.153 | 25.101 |
| 帶息債務/全部投入資本 (%) | 23.429 | 22.708 | 18.337 | 18.550 | -- |
| 股東權益/帶息債務 (%) | 320.535 | 333.256 | 433.349 | 416.264 | 401.392 |
| 股東權益/負債合計 (%) | 244.587 | 234.355 | 276.827 | 268.811 | 298.740 |
| 利息保障倍數 (X) | 5.408 | 6.122 | 5.558 | 49.384 | 10.379 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 147.532 | 136.316 | 101.316 | 61.430 | 0.000 |
| 存貨周轉天數 (天) | 372.715 | 271.296 | 165.152 | 209.273 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 08/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
